Morning Market Losers

By: via Benzinga
Amicus Therapeutics, Inc. (NASDAQ: FOLD) shares tumbled 55.13 percent to $6.17 following U.S. regulatory update for migalastat ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.